Monopar Therapeutics Inc's total assets for Q4 2024 were $60.29M, an increase of 893.32% from the previous quarter. MNPR total liabilities were $5.25M for the fiscal quarter, a 367.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.